Search - tctmd.com

Displaying 301 - 320 of 4093

Sort: Relevancy | Date

Presentation TCT 2024

AI is the Future of PE Care

Presenter: Dan Shilo

October 30, 2024

Presentation TCT 2024

Case Presentation: High/High Intermediate Risk PE

Presenter: Jun Li

October 30, 2024

Presentation TCT 2024

Clinical Trial Update in 2024

Presenter: Akhilesh Sista

October 30, 2024

Presentation TCT 2024

Other Disease Entities Treated With PE Technologies: Vegetations And Masses

Presenter: Sanjum Sethi

October 30, 2024

Presentation TCT 2024

CDT, Medium and Large Bore Devices: How Do We Choose?

Presenter: Tai Kobayashi

October 30, 2024

Presentation TCT 2024

AI Based Image Analysis Algorithms: Implementation and Impact

Presenter: Andrew Sharp

October 30, 2024

Presentation TCT 2024

Advances In Intervention For Chronic PE

Presenter: Vikas Aggarwal

October 30, 2024

Presentation TCT 2024

Clinical Trial Update in 2024

Presenter: Jay Giri

October 30, 2024

Presentation TCT 2024

How Can We Integrate Hemodynamics Into Current Risk Stratification Paradigms?

Presenter: Daniel Burkhoff

October 30, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

News Conference News TCT 2024

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

Todd Neale

October 29, 2024

Presentation TCT 2024

TCT 309: Endovascular Interventions in Patients Hospitalized With Stroke: Trends, Outcomes and Predictors

Presenter: Abdul Rasheed Bahar

October 29, 2024

Presentation TCT 2024

TCT 312: Clinical Predictors of Mortality in Patients With Acute Ischemic Stroke Treated With Mechanical Thrombectomy: A Nonlinear, Internally Validated Model

Presenter: Henriette Mészáros

October 29, 2024

Presentation TCT 2024

Large-bore Mechanical Thrombectomy vs Catheter-directed Thrombolysis for Treatment of Intermediate-Risk Pulmonary Embolism: Primary Outcomes From the PEERLESS Randomized Controlled Trial

Presenter: Wissam Jaber

October 29, 2024

Presentation TCT 2024

TCT 310: Endovascular Treatment of Severely Calcified Carotid Stenosis: Role of IVUS-Guided Procedure

Presenter: Piero Montorsi

October 29, 2024

Presentation TCT 2024

Controversy in Asymptomatic Patients and What Role Will Be Played By CREST 2 Results

Presenter: Teresa Carman

October 29, 2024

Presentation TCT 2024

Protection Options During Trans-Femoral Stenting. What is Available Now?

Presenter: Kenneth Rosenfield

October 29, 2024

Presentation TCT 2024

Extracranial Vertebral Artery Stenting. Where is the Data?

Presenter: Sean Lavine

October 29, 2024

Presentation TCT 2024

Case Presentation: High Risk Asymptomatic Carotid Stenosis Patient

Presenter: Steven Abramowitz

October 29, 2024

Presentation TCT 2024

How to Decide TF Stent vs TCAR vs CEA

Presenter: Michol Cooper

October 29, 2024

Advertisement

AI is the Future of PE Care

Case Presentation: High/High Intermediate Risk PE

Clinical Trial Update in 2024

Other Disease Entities Treated With PE Technologies: Vegetations And Masses

CDT, Medium and Large Bore Devices: How Do We Choose?

AI Based Image Analysis Algorithms: Implementation and Impact

Advances In Intervention For Chronic PE

Clinical Trial Update in 2024

How Can We Integrate Hemodynamics Into Current Risk Stratification Paradigms?

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

TCT 309: Endovascular Interventions in Patients Hospitalized With Stroke: Trends, Outcomes and Predictors

TCT 312: Clinical Predictors of Mortality in Patients With Acute Ischemic Stroke Treated With Mechanical Thrombectomy: A Nonlinear, Internally Validated Model

Large-bore Mechanical Thrombectomy vs Catheter-directed Thrombolysis for Treatment of Intermediate-Risk Pulmonary Embolism: Primary Outcomes From the PEERLESS Randomized Controlled Trial

TCT 310: Endovascular Treatment of Severely Calcified Carotid Stenosis: Role of IVUS-Guided Procedure

Controversy in Asymptomatic Patients and What Role Will Be Played By CREST 2 Results

Protection Options During Trans-Femoral Stenting. What is Available Now?

Extracranial Vertebral Artery Stenting. Where is the Data?

Case Presentation: High Risk Asymptomatic Carotid Stenosis Patient

How to Decide TF Stent vs TCAR vs CEA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content